Kuixi Zhu

Kuixi Zhu is a Principal Research Scientist at The BIO5 Institute, specializing in Bayesian network-based drug target and disease pathology mechanism discovery since March 2018. Previously, Kuixi Zhu served as a Research Scientist at the Icahn School of Medicine at Mount Sinai from October 2014 to March 2018, focusing on biology network construction and computational algorithm improvement. Kuixi Zhu holds a Master's Degree in Biomedical Informatics from Columbia University (2012-2014) and a Bachelor's Degree in Bioinformatics from Harbin Medical University (2007-2012).